DK1248650T3 - Enhanced bovine herpes virus DNA vaccines 1 - Google Patents
Enhanced bovine herpes virus DNA vaccines 1Info
- Publication number
- DK1248650T3 DK1248650T3 DK01907651T DK01907651T DK1248650T3 DK 1248650 T3 DK1248650 T3 DK 1248650T3 DK 01907651 T DK01907651 T DK 01907651T DK 01907651 T DK01907651 T DK 01907651T DK 1248650 T3 DK1248650 T3 DK 1248650T3
- Authority
- DK
- Denmark
- Prior art keywords
- herpes virus
- dna vaccines
- virus dna
- bovine herpes
- enhanced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0000798A FR2804028B1 (en) | 2000-01-21 | 2000-01-21 | IMPROVED DNA VACCINES FOR PENSION ANIMALS |
PCT/FR2001/000187 WO2001052888A2 (en) | 2000-01-21 | 2001-01-19 | Improved dna vaccines for production-type animals |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1248650T3 true DK1248650T3 (en) | 2007-04-16 |
Family
ID=8846183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01907651T DK1248650T3 (en) | 2000-01-21 | 2001-01-19 | Enhanced bovine herpes virus DNA vaccines 1 |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1248650B1 (en) |
JP (1) | JP2004500375A (en) |
KR (1) | KR100820893B1 (en) |
CN (2) | CN1404398B (en) |
AR (1) | AR027926A1 (en) |
AT (1) | ATE346611T1 (en) |
AU (1) | AU783865B2 (en) |
BR (2) | BRPI0107767B1 (en) |
CA (1) | CA2398229C (en) |
CY (1) | CY1107627T1 (en) |
DE (1) | DE60124862T2 (en) |
DK (1) | DK1248650T3 (en) |
ES (1) | ES2277913T3 (en) |
FR (1) | FR2804028B1 (en) |
HU (1) | HU229597B1 (en) |
MX (1) | MXPA02007110A (en) |
NZ (1) | NZ520270A (en) |
PL (1) | PL209304B1 (en) |
PT (1) | PT1248650E (en) |
WO (1) | WO2001052888A2 (en) |
ZA (1) | ZA200205698B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7078388B2 (en) | 2000-01-21 | 2006-07-18 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
PT2311848E (en) | 2002-12-23 | 2013-10-03 | Vical Inc | Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
EP1594537B1 (en) * | 2003-02-19 | 2012-10-24 | Merial | Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3 |
MXPA06005424A (en) | 2003-11-13 | 2007-01-25 | Univ Georgia Res Found | Methods of characterizing infectious bursal disease virus. |
CU23544A1 (en) | 2006-02-28 | 2010-06-17 | Ct Ingenieria Genetica Biotech | CHEMICAL VACCINAL ANTIGENS AGAINST THE CLASSICAL SWINE VIRUS VIRUS |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
RU2585961C9 (en) * | 2009-05-22 | 2016-12-27 | Дженосеа Биосайенсиз Инк. | Vaccine against herpes simplex virus type 2: compositions and methods for triggering immune response |
WO2012065286A1 (en) * | 2010-11-19 | 2012-05-24 | 北京凯因科技股份有限公司 | Composition of dna vaccine for preventing and treating hepatitis b |
CN112034169A (en) * | 2020-08-27 | 2020-12-04 | 华威特(江苏)生物制药有限公司 | Direct immunofluorescence reagent for detecting bovine viral diarrhea virus type 1 and kit thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07504683A (en) * | 1992-07-08 | 1995-05-25 | シェリング・コーポレーション | Use of GM-CSF as a vaccine adjuvant |
EP0702516A4 (en) * | 1993-06-01 | 1998-04-22 | Life Technologies Inc | Genetic immunization with cationic lipids |
US5658785A (en) * | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
EP0779923A2 (en) * | 1994-09-09 | 1997-06-25 | Neurocrine Biosciences, Inc. | Interleukin-1 type 3 receptors |
US5736524A (en) * | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
US5719131A (en) * | 1994-12-09 | 1998-02-17 | Genzyme Corporation | Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules |
JPH11504631A (en) * | 1995-04-25 | 1999-04-27 | バイカル インコーポレイテッド | Single vial formulation of DNA / lipid complex |
CA2220950A1 (en) * | 1995-05-26 | 1996-11-28 | Somatix Therapy Corporation | Delivery vehicles comprising stable lipid/nucleic acid complexes |
FR2751228B1 (en) * | 1996-07-19 | 1998-11-20 | Rhone Merieux | BOVINE POLYNUCLEOTIDE VACCINE FOR INTRADERMAL ROUTE |
FR2751229B1 (en) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | POLYNUCLEOTIDE VACCINE FORMULA IN PARTICULAR AGAINST RESPIRATORY PATHOLOGY OF CATTLE |
FR2751224B1 (en) * | 1996-07-19 | 1998-11-20 | Rhone Merieux | POLYNUCLEOTIDE VACCINE FORMULA AGAINST BREATHING AND PIG REPRODUCTIVE CONDITIONS |
WO1998040499A1 (en) * | 1997-03-10 | 1998-09-17 | Heather Lynn Davis | Gene delivery to mucosal epithelium for immunization or therapeutic purposes |
AUPO856097A0 (en) * | 1997-08-14 | 1997-09-04 | Commonwealth Scientific And Industrial Research Organisation | Vector |
KR100768114B1 (en) * | 1999-06-10 | 2007-10-17 | 메리알 | Dna vaccines for pets and sport animals |
US6943152B1 (en) * | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
-
2000
- 2000-01-21 FR FR0000798A patent/FR2804028B1/en not_active Expired - Lifetime
-
2001
- 2001-01-19 DE DE60124862T patent/DE60124862T2/en not_active Expired - Lifetime
- 2001-01-19 EP EP01907651A patent/EP1248650B1/en not_active Expired - Lifetime
- 2001-01-19 CA CA2398229A patent/CA2398229C/en not_active Expired - Lifetime
- 2001-01-19 WO PCT/FR2001/000187 patent/WO2001052888A2/en active IP Right Grant
- 2001-01-19 AT AT01907651T patent/ATE346611T1/en active
- 2001-01-19 KR KR1020027009300A patent/KR100820893B1/en active IP Right Grant
- 2001-01-19 BR BRPI0107767-8A patent/BRPI0107767B1/en unknown
- 2001-01-19 PL PL356554A patent/PL209304B1/en unknown
- 2001-01-19 BR BR0107767-8A patent/BR0107767A/en not_active IP Right Cessation
- 2001-01-19 CN CN018054072A patent/CN1404398B/en not_active Expired - Lifetime
- 2001-01-19 PT PT01907651T patent/PT1248650E/en unknown
- 2001-01-19 MX MXPA02007110A patent/MXPA02007110A/en active IP Right Grant
- 2001-01-19 CN CNA2008101667835A patent/CN101554480A/en active Pending
- 2001-01-19 HU HU0203974A patent/HU229597B1/en unknown
- 2001-01-19 ES ES01907651T patent/ES2277913T3/en not_active Expired - Lifetime
- 2001-01-19 DK DK01907651T patent/DK1248650T3/en active
- 2001-01-19 AU AU35566/01A patent/AU783865B2/en not_active Expired
- 2001-01-19 JP JP2001552935A patent/JP2004500375A/en active Pending
- 2001-01-19 NZ NZ520270A patent/NZ520270A/en not_active IP Right Cessation
- 2001-01-22 AR ARP010100267A patent/AR027926A1/en not_active Application Discontinuation
-
2002
- 2002-07-17 ZA ZA200205698A patent/ZA200205698B/en unknown
-
2007
- 2007-02-14 CY CY20071100201T patent/CY1107627T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA02007110A (en) | 2003-01-28 |
FR2804028A1 (en) | 2001-07-27 |
EP1248650A2 (en) | 2002-10-16 |
CY1107627T1 (en) | 2013-04-18 |
ES2277913T3 (en) | 2007-08-01 |
WO2001052888A3 (en) | 2001-12-20 |
KR100820893B1 (en) | 2008-04-10 |
HU229597B1 (en) | 2014-02-28 |
KR20020084093A (en) | 2002-11-04 |
JP2004500375A (en) | 2004-01-08 |
NZ520270A (en) | 2004-08-27 |
BR0107767A (en) | 2002-11-12 |
AU3556601A (en) | 2001-07-31 |
CA2398229A1 (en) | 2001-07-26 |
PL209304B1 (en) | 2011-08-31 |
EP1248650B1 (en) | 2006-11-29 |
CN1404398B (en) | 2012-05-02 |
HUP0203974A2 (en) | 2003-03-28 |
ZA200205698B (en) | 2003-09-29 |
AR027926A1 (en) | 2003-04-16 |
FR2804028B1 (en) | 2004-06-04 |
AU783865B2 (en) | 2005-12-15 |
PL356554A1 (en) | 2004-06-28 |
ATE346611T1 (en) | 2006-12-15 |
DE60124862T2 (en) | 2007-07-05 |
PT1248650E (en) | 2007-02-28 |
CN1404398A (en) | 2003-03-19 |
DE60124862D1 (en) | 2007-01-11 |
BRPI0107767B1 (en) | 2017-10-24 |
CN101554480A (en) | 2009-10-14 |
CA2398229C (en) | 2012-05-15 |
WO2001052888A2 (en) | 2001-07-26 |
HUP0203974A3 (en) | 2004-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2016020I1 (en) | HERPES VIRUS STRAIN FOR GENE THERAPY | |
DK1058558T3 (en) | Recombinant and adjuvanted influenza and herpes virus vaccines | |
GB2337755B (en) | Virus vaccine | |
NO20003302D0 (en) | Vaccine | |
ZA975619B (en) | Recombinant live vaccine based on canine herpesvirus in particular against carre's disease rabies or the para-influenza virus type 2 | |
HK1046243B (en) | Aids virus vaccines using sendai virus vector | |
NO20014322D0 (en) | Vaccine | |
AU4932601A (en) | Recombinant parainfluenza virus expression systems and vaccines | |
DE60002650D1 (en) | Oil-vaccinated vaccine | |
MA25489A1 (en) | VACCINES | |
FR2776928B1 (en) | ADJUVATED DNA VACCINES | |
DK1248650T3 (en) | Enhanced bovine herpes virus DNA vaccines 1 | |
EP1204424A4 (en) | Recombinant rsv virus expression systems and vaccines | |
DK1372712T3 (en) | Vaccine against equine herpes virus | |
ATE519775T1 (en) | RECOMBINANT SUBUNIT VACCINES | |
HUP0200560A2 (en) | Bhv-1 gene-deleted virus vaccine | |
ATE295182T1 (en) | COMPOSITIONS FOR IMMUNO-BOOSTING VACCINES | |
EP1490396A4 (en) | Immunogenic hiv peptides for use as reagents and vaccines | |
IS2797B (en) | Vaccine against ISA virus | |
HUP0002908A2 (en) | Recombinant newcastle disease virus as embryo vaccine | |
EP1296710A4 (en) | Recombinant vaccines against infectious bursal disease virus | |
SI1155119T1 (en) | Bhv-1 gene-deleted virus vaccine | |
GB9917981D0 (en) | Viral vaccine | |
GB9826647D0 (en) | DNA vaccines | |
NO20002213D0 (en) | Babesia vaccine |